Alpa Laboratories Limited (ALPA.NS)
INR 119.95
(1.15%)
INR 119.95
(1.15%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 58.52 Million | -48.45 Million | 21.7 Million | -16.92 Million | 177.82 Million | -15.9 Million |
| Net Income | 167.76 Million | 157.3 Million | 195.8 Million | 107.86 Million | 29.07 Million | 25.4 Million |
| Depreciation & Amortization | 19.54 Million | 13.28 Million | 16.6 Million | 12.28 Million | 31.64 Million | 31.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -40.58 Million | -155.1 Million | -58.5 Million | -103.27 Million | 101.51 Million | -27.2 Million |
| Other non-cash items | -21.8 Million | -63.92 Million | -132.2 Million | -33.8 Million | 15.58 Million | -45.3 Million |
| Investing Cash Flow | -158.99 Million | 11.69 Million | -156.1 Million | 58.6 Million | -111.72 Million | -144 Million |
| Investments in PPE | -63.85 Million | -11.28 Million | -21.9 Million | -32.16 Million | -25.45 Million | -8.5 Million |
| Acquisitions | - | -487 Thousand | -100 Thousand | 3.74 Million | 13.71 Million | -55.3 Million |
| Investment purchases | -95.13 Million | -4.61 Million | -149.4 Million | -3.74 Million | -116.08 Million | -118.7 Million |
| Sales/Maturities of investments | - | 2.57 Million | 149.48 Million | 79.08 Million | 16.19 Million | 38.63 Million |
| Other Investing Activities | -1000.00 | 25.49 Million | -134.18 Million | 11.68 Million | -101 Thousand | -131 Thousand |
| Financing Cash Flow | 29.42 Million | -34.76 Million | 54.4 Million | 1.85 Million | -13.49 Million | -47.8 Million |
| Debt repayment | -37.19 Million | -35.43 Million | -21.2 Million | -1.82 Million | -12.72 Million | -43.26 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -7.77 Million | 666 Thousand | 75.6 Million | 3.68 Million | -768 Thousand | -4.53 Million |
| Accounts receivables | 20.01 Million | -66.41 Million | 75.85 Million | -185.1 Million | 97.76 Million | -72.37 Million |
| Accounts payables | -37.07 Million | 19.8 Million | -78.9 Million | 127.22 Million | -12.08 Million | 18.95 Million |
| Inventory | -10.24 Million | 28.22 Million | 11 Million | -40.09 Million | 14.88 Million | -3.2 Million |
| Other working capital | -13.28 Million | -136.72 Million | -66.45 Million | -5.3 Million | 956 Thousand | 29.42 Million |
| Cash at beginning of period | 88.13 Million | 25.05 Million | 105.1 Million | 61.69 Million | 8.99 Million | 213.4 Million |
| Cash at end of period | 17.1 Million | -46.47 Million | 25.1 Million | 105.22 Million | 61.66 Million | 5.8 Million |
| Capital Expenditure | -63.85 Million | -11.28 Million | -21.9 Million | -32.16 Million | -25.45 Million | -8.5 Million |
| Effect of forex changes on cash | - | 143.91 Million | -9.34 Million | -129 Thousand | 101 Thousand | 3.19 Million |
| Net cash flow / Change in cash | -71.03 Million | -71.52 Million | -80 Million | 43.53 Million | 52.67 Million | -207.6 Million |
| Free Cash Flow | -5.32 Million | -59.73 Million | -200 Thousand | -49.09 Million | 152.36 Million | -24.4 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 167.76 Million | 35.53 Million | 45.09 Million | 57.89 Million | 30.33 Million | 157.3 Million |
| Depreciation & Amortization | 19.54 Million | - | 6.61 Million | 4.92 Million | 2.75 Million | 13.28 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -40.58 Million | - | - | - | - | -155.1 Million |
| Other non-cash items | -21.8 Million | -35.53 Million | -45.09 Million | -57.89 Million | -30.33 Million | -63.92 Million |
| Investing Cash Flow | -158.99 Million | - | - | - | - | 11.69 Million |
| Investments in PPE | -63.85 Million | - | - | - | - | -11.28 Million |
| Acquisitions | - | - | - | - | - | -487 Thousand |
| Investment purchases | -95.13 Million | - | - | - | - | -4.61 Million |
| Sales/Maturities of investments | - | - | - | - | - | 2.57 Million |
| Other Investing Activities | -1000.00 | - | - | - | - | 25.49 Million |
| Financing Cash Flow | 29.42 Million | - | - | - | - | -34.76 Million |
| Debt repayment | -37.19 Million | - | - | - | - | -35.43 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -7.77 Million | - | - | - | - | 666 Thousand |
| Accounts receivables | 20.01 Million | - | - | - | - | -66.41 Million |
| Accounts payables | -37.07 Million | - | - | - | - | 19.8 Million |
| Inventory | -10.24 Million | - | - | - | - | 28.22 Million |
| Other working capital | -13.28 Million | - | - | - | - | -136.72 Million |
| Cash at beginning of period | 88.13 Million | - | 24.13 Million | 14.27 Million | 88.13 Million | 25.05 Million |
| Cash at end of period | 17.1 Million | - | 37.36 Million | 24.13 Million | 93.64 Million | -46.47 Million |
| Capital Expenditure | -63.85 Million | - | - | - | - | -11.28 Million |
| Effect of forex changes on cash | - | - | - | - | - | 143.91 Million |
| Net cash flow / Change in cash | -71.03 Million | - | 13.23 Million | 9.85 Million | 5.51 Million | -71.52 Million |
| Free Cash Flow | -5.32 Million | - | 13.23 Million | 9.85 Million | 5.51 Million | -59.73 Million |
WKGBF
000153
3294
8409
600198
GH